Abstract:Introduction: We aimed to verify the application value of the Alberta Stroke Program Early CT Score (ASPECTS) based on multiple post-labeling delay (multi-PLD) arterial spin labeling (ASL) for outcome assessment in acute ischemic stroke (AIS) patients. Method: The endpoint was modified Rankin scale score at 90 days (90-day mRS). Patients were divided into the good outcome (0–2) and poor outcome (3–6) groups. The independent samples t -test, Mann-Whitney U -test, and χ 2 -test were used to compare clinical and imaging parameters between groups. We used partial correlation analysis to evaluate the relationships between ASPECTS and outcomes. Multivariate logistic regression analysis was used to examine potential independent prognostic indicators. The receiver operating characteristic (ROC) curve analysis was used to evaluate the performance of the independent prognostic indicators in predicting outcomes. Results: Fifty-five AIS patients were included. The good outcome group had a lower baseline National Institutes of Health Stroke Scale (NIHSS; Z = −3.413, P < 0.001) and infarct core volume (ICV; Z = −3.114, P = 0.002) as well as higher cerebral blood flow (CBF)-ASPECTS ( Z = −3.835, P < 0.001) and cerebral blood volume (CBV)-ASPECTS ( Z = −4.099, P < 0.001). Higher CBF-ASPECTS ( r = −0.459, P = 0.001), and CBV-ASPECTS ( r = −0.502, P < 0.001) were associated with a lower 90-day mRS. The baseline NIHSS, CBF-ASPECTS, and CBV-ASPECTS were identified as independent prognostic indicators. The AUCs of the baseline NIHSS, CBF-ASPECTS, and CBV-ASPECTS were 83.3, 87.4, and 89.9%, respectively. Combining NIHSS with CBF-ASPECTS and CBV-ASPECTS, the AUC significantly improved to 96.3%. The combined three factors showed a significant difference compared to the baseline NIHSS ( Z = 2.039, P = 0.041) and CBF-ASPECTS ( Z = 2.099, P = 0.036), but no difference with CBV-ASPECTS ( Z = 1.176, P = 0.239). Conclusions: The ASPECTS based on multi-PLD ASL is a valuable tool for identifying independent prognostic indicators and assessing clinical outcomes in AIS patients. The baseline NIHSS, combined with CBF-ASPECTS and CBV-ASPECTS, enhances the predictive efficacy of clinical outcomes in AIS patients. The CBV-ASPECTS alone can offer comparable predictive efficacy to the combination.

Arterial transit artifact as a short-term prognostic indicator in acute ischemic stroke

Application Progress of Arterial Spin Labeling Technology in the Field of Cognitive Dysfunction

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke.

Acute Stroke: Prognostic Value of Quantitative Collateral Assessment at Perfusion CT.

Presence of Multi-Segment Clot Sign on Dynamic CT Angiography: a Predictive Imaging Marker of Recanalisation and Good Outcome in Acute Ischaemic Stroke Patients

Imaging Markers in Acute Phase of Stroke: Implications for Prognosis

Arterial Transit Artifacts Observed on Arterial Spin Labeling Perfusion Imaging of Carotid Artery Stenosis Patients: What are Counterparts on Symptomatology, Dynamic Susceptibility Contrast Perfusion, and Digital Subtraction Angiography?

Regional Arterial Spin Labeling Perfusion Defect Is Associated With Early Ischemic Recurrence in Patients With a Transient Ischemic Attack

Prognostic value of multi-PLD ASL-based cerebral perfusion ASPECTS in acute ischemic stroke

Evaluation of T2-FLAIR combined with ASL on the collateral circulation of acute ischemic stroke

Collateral Circulation Predicts 3-month Functional Outcomes of Subacute Ischemic Stroke Patients: A Study Combining Arterial Spin Labeling and MR Angiography

Antegrade Blood Flow on 4‐dimensional Computed Tomography Angiography Predict Stroke Subtype in Patients with Acute Large Artery Occlusion

Presence of Anterior Temporal Artery Associates with Good Outcome in Acute Atherosclerotic M1-middle Cerebral Artery Occlusion

Arterial Spin Labeling‐Based MRI Estimation of Penumbral Tissue in Acute Ischemic Stroke

Aspartate aminotransferase to alanine aminotransferase ratio and clinical outcomes after acute ischemic stroke: the CNSR-III registry

Amide proton transfer MRI may reflect effective reperfusion and predict functional outcomes in patients with ischemic stroke

Cerebral blood flow from arterial spin labeling as an imaging biomarker of outcome after endovascular therapy for ischemic stroke

Multi-phase computed tomography angiography combined with inflammation index to predict clinical functional prognosis in patients with acute ischemic stroke

Diffusion-weighted Imaging and Arterial Spin Labeling for Prediction of Cerebral Infarct Volume in Acute Atherothrombotic Stroke

Metabolomic Characterization of Acute Ischemic Stroke Facilitates Metabolomic Biomarker Discovery

Multidelay Arterial Spin Labeling Versus Computed Tomography Perfusion in Penumbra Volume of Acute Ischemic Stroke